Sterling Investment Advisors (Pennsylvania)’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-125
Closed -$30K 599
2021
Q4
$30K Hold
125
0.01% 317
2021
Q3
$29K Hold
125
0.01% 316
2021
Q2
$26K Hold
125
0.01% 325
2021
Q1
$26K Hold
125
0.01% 304
2020
Q4
$27K Hold
125
0.01% 280
2020
Q3
$23K Hold
125
0.01% 277
2020
Q2
$23K Hold
125
0.01% 280
2020
Q1
$25K Hold
125
0.01% 244
2019
Q4
$23K Hold
125
0.01% 285
2019
Q3
$20K Hold
125
0.01% 292
2019
Q2
$31K Hold
125
0.02% 256
2019
Q1
$30K Hold
125
0.02% 259
2018
Q4
$28K Hold
125
0.02% 256
2018
Q3
$35K Hold
125
0.02% 262
2018
Q2
$36K Hold
125
0.02% 235
2018
Q1
$32K Hold
125
0.02% 248
2017
Q4
$27K Sell
125
-100
-44% -$20.2K 0.02% 241
2017
Q3
$42K Hold
225
0.03% 194
2017
Q2
$39K Sell
225
-175
-44% -$28.1K 0.03% 197
2017
Q1
$61K Sell
400
-100
-20% -$14.6K 0.04% 158
2016
Q4
$74K Buy
+500
New +$72.4K 0.06% 137

Other funds holding ICUI

Sterling Investment Advisors (Pennsylvania)'s ICUI Position: Q1 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of ICU Medical (ICUI) in Q1 2022, closing a stake of 125 shares — an estimated $30K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in ICUI in Q4 2016 and held it in 21 quarters. The position peaked at $74K in Q4 2016. 295 funds tracked by Wall St. Rank hold ICUI as of Q1 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining ICU Medical position as of Q1 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 125 ICU Medical shares in Q1 2022, an estimated $30K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in ICU Medical in Q4 2016 and held it in 21 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s ICU Medical position peaked at $74K in Q4 2016.
  • 295 funds tracked by Wall St. Rank held ICU Medical as of Q1 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q1 2022, filed 3 May 2022.